Strategic pain management: The identification and development of the IAHPC opioid essential prescription package

Ernesto Vignaroli, Michael I. Bennett, Cheryl Nekolaichuk, Liliana De Lima, Roberto Wenk, Carla I. Ripamonti, Eduardo Bruera

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of this study was to determine by consensus the components of an opioid essential prescription package (OEPP) to be used when initiating a prescription for the control of moderate to severe chronic pain. Palliative care physicians (n=60) were sampled from the International Association for Hospice and Palliative Care (IAHPC) membership list to represent a range of countries of varying economic levels and diverse geographical regions. Using a Delphi study method, physicians were asked to rank preferences of drug and dosing schedule for first-line opioid, antiemetic, and laxative for the treatment of adults with chronic pain due to cancer and other life-threatening conditions. Overall response rates after two Delphi survey rounds were 95% (n=57) and 82% (n=49), respectively. A consensus (set at ≥75% agreement) was reached to include morphine as first-line opioid at a dose of 5mg orally every 4 hours. Consensus was reached to include metoclopramide as a first-line antiemetic, but there was no consensus on "regular" or "as needed" administration. No consensus was reached regarding a first-line laxative, but a combination of senna and docusate secured 59% agreement. There was consensus (93% agreement) that laxatives should always be given regularly when opioid treatment is started. Further work is needed to establish a recommended dose of metoclopramide and a type and dose of laxative. The resulting OEPP is international in scope and is designed to ensure that opioids are better tolerated by reducing adverse effects of opioids, which could lead to more sustained improvements in pain management.

Original languageEnglish
Pages (from-to)186-191
Number of pages6
JournalJournal of Palliative Medicine
Volume15
Issue number2
DOIs
Publication statusPublished - Feb 1 2012

Fingerprint

Hospice Care
Pain Management
Palliative Care
Opioid Analgesics
Prescriptions
Laxatives
Metoclopramide
Antiemetics
Chronic Pain
Dioctyl Sulfosuccinic Acid
Delphi Technique
Physicians
Morphine
Appointments and Schedules
Economics
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Anesthesiology and Pain Medicine
  • Nursing(all)

Cite this

Strategic pain management : The identification and development of the IAHPC opioid essential prescription package. / Vignaroli, Ernesto; Bennett, Michael I.; Nekolaichuk, Cheryl; De Lima, Liliana; Wenk, Roberto; Ripamonti, Carla I.; Bruera, Eduardo.

In: Journal of Palliative Medicine, Vol. 15, No. 2, 01.02.2012, p. 186-191.

Research output: Contribution to journalArticle

Vignaroli, Ernesto ; Bennett, Michael I. ; Nekolaichuk, Cheryl ; De Lima, Liliana ; Wenk, Roberto ; Ripamonti, Carla I. ; Bruera, Eduardo. / Strategic pain management : The identification and development of the IAHPC opioid essential prescription package. In: Journal of Palliative Medicine. 2012 ; Vol. 15, No. 2. pp. 186-191.
@article{13dbd4df1ad048f5acbe4c5b67f76a99,
title = "Strategic pain management: The identification and development of the IAHPC opioid essential prescription package",
abstract = "The aim of this study was to determine by consensus the components of an opioid essential prescription package (OEPP) to be used when initiating a prescription for the control of moderate to severe chronic pain. Palliative care physicians (n=60) were sampled from the International Association for Hospice and Palliative Care (IAHPC) membership list to represent a range of countries of varying economic levels and diverse geographical regions. Using a Delphi study method, physicians were asked to rank preferences of drug and dosing schedule for first-line opioid, antiemetic, and laxative for the treatment of adults with chronic pain due to cancer and other life-threatening conditions. Overall response rates after two Delphi survey rounds were 95{\%} (n=57) and 82{\%} (n=49), respectively. A consensus (set at ≥75{\%} agreement) was reached to include morphine as first-line opioid at a dose of 5mg orally every 4 hours. Consensus was reached to include metoclopramide as a first-line antiemetic, but there was no consensus on {"}regular{"} or {"}as needed{"} administration. No consensus was reached regarding a first-line laxative, but a combination of senna and docusate secured 59{\%} agreement. There was consensus (93{\%} agreement) that laxatives should always be given regularly when opioid treatment is started. Further work is needed to establish a recommended dose of metoclopramide and a type and dose of laxative. The resulting OEPP is international in scope and is designed to ensure that opioids are better tolerated by reducing adverse effects of opioids, which could lead to more sustained improvements in pain management.",
author = "Ernesto Vignaroli and Bennett, {Michael I.} and Cheryl Nekolaichuk and {De Lima}, Liliana and Roberto Wenk and Ripamonti, {Carla I.} and Eduardo Bruera",
year = "2012",
month = "2",
day = "1",
doi = "10.1089/jpm.2011.0296",
language = "English",
volume = "15",
pages = "186--191",
journal = "Journal of Palliative Medicine",
issn = "1096-6218",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Strategic pain management

T2 - The identification and development of the IAHPC opioid essential prescription package

AU - Vignaroli, Ernesto

AU - Bennett, Michael I.

AU - Nekolaichuk, Cheryl

AU - De Lima, Liliana

AU - Wenk, Roberto

AU - Ripamonti, Carla I.

AU - Bruera, Eduardo

PY - 2012/2/1

Y1 - 2012/2/1

N2 - The aim of this study was to determine by consensus the components of an opioid essential prescription package (OEPP) to be used when initiating a prescription for the control of moderate to severe chronic pain. Palliative care physicians (n=60) were sampled from the International Association for Hospice and Palliative Care (IAHPC) membership list to represent a range of countries of varying economic levels and diverse geographical regions. Using a Delphi study method, physicians were asked to rank preferences of drug and dosing schedule for first-line opioid, antiemetic, and laxative for the treatment of adults with chronic pain due to cancer and other life-threatening conditions. Overall response rates after two Delphi survey rounds were 95% (n=57) and 82% (n=49), respectively. A consensus (set at ≥75% agreement) was reached to include morphine as first-line opioid at a dose of 5mg orally every 4 hours. Consensus was reached to include metoclopramide as a first-line antiemetic, but there was no consensus on "regular" or "as needed" administration. No consensus was reached regarding a first-line laxative, but a combination of senna and docusate secured 59% agreement. There was consensus (93% agreement) that laxatives should always be given regularly when opioid treatment is started. Further work is needed to establish a recommended dose of metoclopramide and a type and dose of laxative. The resulting OEPP is international in scope and is designed to ensure that opioids are better tolerated by reducing adverse effects of opioids, which could lead to more sustained improvements in pain management.

AB - The aim of this study was to determine by consensus the components of an opioid essential prescription package (OEPP) to be used when initiating a prescription for the control of moderate to severe chronic pain. Palliative care physicians (n=60) were sampled from the International Association for Hospice and Palliative Care (IAHPC) membership list to represent a range of countries of varying economic levels and diverse geographical regions. Using a Delphi study method, physicians were asked to rank preferences of drug and dosing schedule for first-line opioid, antiemetic, and laxative for the treatment of adults with chronic pain due to cancer and other life-threatening conditions. Overall response rates after two Delphi survey rounds were 95% (n=57) and 82% (n=49), respectively. A consensus (set at ≥75% agreement) was reached to include morphine as first-line opioid at a dose of 5mg orally every 4 hours. Consensus was reached to include metoclopramide as a first-line antiemetic, but there was no consensus on "regular" or "as needed" administration. No consensus was reached regarding a first-line laxative, but a combination of senna and docusate secured 59% agreement. There was consensus (93% agreement) that laxatives should always be given regularly when opioid treatment is started. Further work is needed to establish a recommended dose of metoclopramide and a type and dose of laxative. The resulting OEPP is international in scope and is designed to ensure that opioids are better tolerated by reducing adverse effects of opioids, which could lead to more sustained improvements in pain management.

UR - http://www.scopus.com/inward/record.url?scp=84857461867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857461867&partnerID=8YFLogxK

U2 - 10.1089/jpm.2011.0296

DO - 10.1089/jpm.2011.0296

M3 - Article

C2 - 22014206

AN - SCOPUS:84857461867

VL - 15

SP - 186

EP - 191

JO - Journal of Palliative Medicine

JF - Journal of Palliative Medicine

SN - 1096-6218

IS - 2

ER -